{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:30:33Z","timestamp":1790508633206,"version":"4.1.0"},"reference-count":112,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002803","name":"Fondazione Cariplo","doi-asserted-by":"publisher","award":["2021-1563"],"award-info":[{"award-number":["2021-1563"]}],"id":[{"id":"10.13039\/501100002803","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004710","name":"Fondazione Umberto Veronesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["23151"],"award-info":[{"award-number":["23151"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015565","name":"Consorzio Interuniversitario Biotecnologie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015565","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.bbcan.2024.189104","type":"journal-article","created":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T11:26:17Z","timestamp":1714562777000},"page":"189104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Cancer stem-like cells in uveal melanoma: novel insights and therapeutic implications"],"prefix":"10.1016","volume":"1879","author":[{"given":"Alessandra","family":"Loda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Semeraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Parolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Ronca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Rezzola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbcan.2024.189104_bb0005","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.mcna.2021.02.005","article-title":"Ocular oncology-primary and metastatic malignancies","volume":"105","author":"Williams","year":"2021","journal-title":"Med. Clin. North Am."},{"key":"10.1016\/j.bbcan.2024.189104_bb0010","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3109\/09273948.2012.702843","article-title":"Genetics of primary intraocular tumors","volume":"20","author":"Nagarkatti-Gude","year":"2012","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.bbcan.2024.189104_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23073835","article-title":"Exploring the FGF\/FGFR system in ocular tumors: new insights and perspectives","volume":"23","author":"Loda","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2024.189104_bb0020","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1053\/j.sult.2010.10.009","article-title":"Ocular anatomy and cross-sectional imaging of the eye","volume":"32","author":"Malhotra","year":"2011","journal-title":"Semin. Ultrasound CT MR"},{"key":"10.1016\/j.bbcan.2024.189104_bb0025","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.mric.2006.06.007","article-title":"Anatomy and pathology of the eye: role of MR imaging and CT","volume":"14","author":"Mafee","year":"2006","journal-title":"Magn. Reson. Imaging Clin. N. Am."},{"key":"10.1016\/j.bbcan.2024.189104_bb0030","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.3892\/etm.2021.10863","article-title":"Uveal melanoma diagnosis and current treatment options (review)","volume":"22","author":"Branisteanu","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.bbcan.2024.189104_bb0035","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/PPO.0b013e31824bd256","article-title":"Metastatic uveal melanoma: biology and emerging treatments","volume":"18","author":"Woodman","year":"2012","journal-title":"Cancer J."},{"key":"10.1016\/j.bbcan.2024.189104_bb0040","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/ajcp\/aqad029","article-title":"Multiorgan involvement of dormant uveal melanoma micrometastases in postmortem tissue from patients without coexisting macrometastases","volume":"160","author":"Gill","year":"2023","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.bbcan.2024.189104_bb0045","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.molonc.2016.09.009","article-title":"Tumor cell dormancy","volume":"11","author":"Gomis","year":"2017","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.bbcan.2024.189104_bb0050","series-title":"Incidence, Prevalence and Epidemiology of Ocular Melanoma","author":"Kivel\u00e4","year":"2014"},{"key":"10.1016\/j.bbcan.2024.189104_bb0055","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1002\/cncr.29727","article-title":"Uveal melanoma: from diagnosis to treatment and the science in between","volume":"122","author":"Chattopadhyay","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.bbcan.2024.189104_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.828112","article-title":"Genetic basis and molecular mechanisms of uveal melanoma metastasis: a focus on prognosis","volume":"12","author":"Gallenga","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2024.189104_bb0065","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2021.5190","article-title":"Current molecular and clinical insights into uveal melanoma (review)","volume":"58","author":"Fallico","year":"2021","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbcan.2024.189104_bb0070","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1167\/iovs.06-0101","article-title":"Clinical and cytogenetic analyses in uveal melanoma","volume":"47","author":"Kilic","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.bbcan.2024.189104_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2022.100121","article-title":"Improved uveal melanoma copy number subtypes including an ultra-high-risk group","volume":"2","author":"Lalonde","year":"2022","journal-title":"Ophthalmol. Sci."},{"key":"10.1016\/j.bbcan.2024.189104_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241612807","article-title":"Genetic and epigenetic features of uveal melanoma-an overview and clinical implications","volume":"24","author":"Pa\u0161ali\u0107","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2024.189104_bb0085","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ccell.2017.07.003","article-title":"Integrative analysis identifies four molecular and clinical subsets in Uveal Melanoma","volume":"32","author":"Robertson","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2024.189104_bb0090","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1158\/2159-8290.CD-13-0330","article-title":"SF3B1 mutations are associated with alternative splicing in uveal melanoma","volume":"3","author":"Furney","year":"2013","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbcan.2024.189104_bb0095","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41698-021-00226-8","article-title":"BAP1 methylation: a prognostic marker of uveal melanoma metastasis","volume":"5","author":"Bakhoum","year":"2021","journal-title":"NPJ Precis. Oncol."},{"key":"10.1016\/j.bbcan.2024.189104_bb0100","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/978-1-62703-727-3_22","article-title":"A prognostic test to predict the risk of metastasis in uveal melanoma based on a 15-gene expression profile","volume":"1102","author":"Harbour","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bbcan.2024.189104_bb0105","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1007\/s00417-019-04335-w","article-title":"Relationship between clinical features, GEP class, and PRAME expression in uveal melanoma","volume":"257","author":"Schefler","year":"2019","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.bbcan.2024.189104_bb0110","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2147\/OPTH.S129645","article-title":"Brachytherapy for patients with uveal melanoma: historical perspectives and future treatment directions","volume":"12","author":"Brewington","year":"2018","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.bbcan.2024.189104_bb0115","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1007\/s00417-011-1733-6","article-title":"Primary transpupillary thermotherapy for small choroidal melanoma","volume":"249","author":"Chojniak","year":"2011","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.bbcan.2024.189104_bb0120","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/ceo.14214","article-title":"Current management of uveal melanoma: a review","volume":"51","author":"Bai","year":"2023","journal-title":"Clin. Experiment. Ophthalmol."},{"key":"10.1016\/j.bbcan.2024.189104_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2022.101041","article-title":"Metastatic uveal melanoma: the final frontier","volume":"90","author":"Rantala","year":"2022","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.bbcan.2024.189104_bb0130","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1038\/s41417-022-00558-y","article-title":"Novel treatment paradigms for metastatic uveal melanoma","volume":"29","author":"Patel","year":"2022","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.bbcan.2024.189104_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2023.102599","article-title":"Uveal melanoma: in the era of new treatments","volume":"119","author":"Wespiser","year":"2023","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.bbcan.2024.189104_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11060846","article-title":"Targeted therapy of uveal melanoma: recent failures and new perspectives","volume":"11","author":"Croce","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2024.189104_bb0145","doi-asserted-by":"crossref","DOI":"10.1177\/1758834018757175","article-title":"Treatment of uveal melanoma: where are we now?","volume":"10","author":"Yang","year":"2018","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.bbcan.2024.189104_bb0150","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/s41467-019-14256-1","article-title":"Single-cell analysis reveals new evolutionary complexity in uveal melanoma","volume":"11","author":"Durante","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2024.189104_bb0155","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaf8399","article-title":"Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy","volume":"355","author":"Davoli","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2024.189104_bb0160","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nature25432","article-title":"Chromosomal instability drives metastasis through a cytosolic DNA response","volume":"553","author":"Bakhoum","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2024.189104_bb0165","doi-asserted-by":"crossref","DOI":"10.1177\/17588359231160140","article-title":"Tebentafusp: a first-in-class treatment for metastatic uveal melanoma","volume":"15","author":"Howlett","year":"2023","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.bbcan.2024.189104_bb0170","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2147\/DDDT.S368954","article-title":"Tebentafusp in the treatment of metastatic uveal melanoma: patient selection and special considerations","volume":"17","author":"Montazeri","year":"2023","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.bbcan.2024.189104_bb0175","first-page":"197","article-title":"Dormancy, stemness, and therapy resistance: interconnected players in cancer evolution","volume":"42","author":"Francescangeli","year":"2023","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.bbcan.2024.189104_bb0180","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.semcancer.2019.08.019","article-title":"Paradoxical effects of chemotherapy on tumor relapse and metastasis promotion","volume":"60","author":"D\u2019Alterio","year":"2020","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bbcan.2024.189104_bb0185","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1007\/s00018-015-1920-4","article-title":"Cancer stem cells: a potential target for cancer therapy","volume":"72","author":"Qiu","year":"2015","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbcan.2024.189104_bb0190","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s12015-019-09887-2","article-title":"Cancer stem cells: acquisition, characteristics, therapeutic implications, targeting strategies and future prospects","volume":"15","author":"Yadav","year":"2019","journal-title":"Stem Cell Rev. Rep."},{"key":"10.1016\/j.bbcan.2024.189104_bb0195","doi-asserted-by":"crossref","first-page":"117","DOI":"10.5483\/BMBRep.2017.50.3.222","article-title":"Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting","volume":"50","author":"Eun","year":"2017","journal-title":"BMB Rep."},{"key":"10.1016\/j.bbcan.2024.189104_bb0200","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/nm.4409","article-title":"Cancer stem cells revisited","volume":"23","author":"Batlle","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2024.189104_bb0205","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18122574","article-title":"Drug resistance driven by cancer stem cells and their niche","volume":"18","author":"Prieto-Vila","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2024.189104_bb0210","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nm0797-730","article-title":"Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell","volume":"3","author":"Bonnet","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2024.189104_bb0215","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/resp.12094","article-title":"Cancer stem cells in lung cancer: evidence and controversies","volume":"18","author":"Alamgeer","year":"2013","journal-title":"Respirology"},{"key":"10.1016\/j.bbcan.2024.189104_bb0220","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1172\/JCI66024","article-title":"Cancer stem cells in the development of liver cancer","volume":"123","author":"Yamashita","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2024.189104_bb0225","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1073\/pnas.0530291100","article-title":"Prospective identification of tumorigenic breast cancer cells","volume":"100","author":"Al-Hajj","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbcan.2024.189104_bb0230","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1002\/stem.30","article-title":"Identification of gastric cancer stem cells using the cell surface marker CD44","volume":"27","author":"Takaishi","year":"2009","journal-title":"Stem Cells"},{"key":"10.1016\/j.bbcan.2024.189104_bb0235","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1158\/0008-5472.CAN-06-2030","article-title":"Identification of pancreatic cancer stem cells","volume":"67","author":"Li","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2024.189104_bb0240","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1080\/07357900801941845","article-title":"Bladder cancer initiating cells (BCICs) are among EMA-CD44v6+ subset: novel methods for isolating undetermined cancer stem (initiating) cells","volume":"26","author":"Yang","year":"2008","journal-title":"Cancer Investig."},{"key":"10.1016\/j.bbcan.2024.189104_bb0245","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/stem.1031","article-title":"Colorectal cancer stem cells","volume":"30","author":"Vaiopoulos","year":"2012","journal-title":"Stem Cells"},{"key":"10.1016\/j.bbcan.2024.189104_bb0250","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nature06489","article-title":"Identification of cells initiating human melanomas","volume":"451","author":"Schatton","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2024.189104_bb0255","doi-asserted-by":"crossref","first-page":"8458","DOI":"10.1167\/iovs.11-7379","article-title":"Uveal melanoma cell lines contain stem-like cells that self-renew, produce differentiated progeny, and survive chemotherapy","volume":"52","author":"Kalirai","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.bbcan.2024.189104_bb0260","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.3389\/fimmu.2020.01280","article-title":"Cancer stem cells-origins and biomarkers: perspectives for targeted personalized therapies","volume":"11","author":"Walcher","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2024.189104_bb0265","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/978-1-4939-7401-6_2","article-title":"Surface markers for the identification of cancer stem cells","volume":"1692","author":"Gopalan","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bbcan.2024.189104_bb0270","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2174\/1574888X13666180810120012","article-title":"ALDH as a stem cell marker in solid tumors","volume":"14","author":"Toledo-Guzm\u00e1n","year":"2019","journal-title":"Curr. Stem Cell Res. Ther."},{"key":"10.1016\/j.bbcan.2024.189104_bb0275","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/cas.13155","article-title":"Tumor-derived spheroids: relevance to cancer stem cells and clinical applications","volume":"108","author":"Ishiguro","year":"2017","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbcan.2024.189104_bb0280","doi-asserted-by":"crossref","first-page":"8721","DOI":"10.7150\/thno.41648","article-title":"Stem cell programs in cancer initiation, progression, and therapy resistance","volume":"10","author":"Huang","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.bbcan.2024.189104_bb0285","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.3390\/cancers7030851","article-title":"Hedgehog signaling in the maintenance of cancer stem cells","volume":"7","author":"Cochrane","year":"2015","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2024.189104_bb0290","doi-asserted-by":"crossref","DOI":"10.3390\/cells9081879","article-title":"Cancer stem cells, quo vadis? The notch signaling pathway in tumor initiation and progression","volume":"9","author":"Meisel","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.bbcan.2024.189104_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2019.03.005","article-title":"Role of OCT4 in cancer stem-like cells and chemotherapy resistance","volume":"1866","author":"Mohiuddin","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.bbcan.2024.189104_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2022.146448","article-title":"Nanog, as a key cancer stem cell marker in tumor progression","volume":"827","author":"Vasefifar","year":"2022","journal-title":"Gene"},{"key":"10.1016\/j.bbcan.2024.189104_bb0305","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.semcancer.2019.09.007","article-title":"Cancer stem cells and their unique role in metastatic spread","volume":"60","author":"Steinbichler","year":"2020","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bbcan.2024.189104_bb0310","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/ncb2976","article-title":"Oncogenic roles of EMT-inducing transcription factors","volume":"16","author":"Puisieux","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbcan.2024.189104_bb0315","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrclinonc.2017.44","article-title":"EMT, CSCs, and drug resistance: the mechanistic link and clinical implications","volume":"14","author":"Shibue","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2024.189104_bb0320","doi-asserted-by":"crossref","DOI":"10.3390\/cells8080926","article-title":"Cancer stem cells and targeting strategies","volume":"8","author":"Barbato","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.bbcan.2024.189104_bb0325","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1158\/1535-7163.MCT-11-1040","article-title":"DNA damage repair pathways in cancer stem cells","volume":"11","author":"Maugeri-Sacc\u00e0","year":"2012","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbcan.2024.189104_bb0330","doi-asserted-by":"crossref","first-page":"11018","DOI":"10.18632\/oncotarget.6920","article-title":"Aldehyde dehydrogenase 1A1 in stem cells and cancer","volume":"7","author":"Tomita","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2024.189104_bb0335","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10911-009-9109-9","article-title":"ABC transporters, drug resistance, and cancer stem cells","volume":"14","author":"Dean","year":"2009","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"10.1016\/j.bbcan.2024.189104_bb0340","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nrclinonc.2015.61","article-title":"Targeting notch, hedgehog, and Wnt pathways in cancer stem cells: clinical update","volume":"12","author":"Takebe","year":"2015","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2024.189104_bb0345","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41392-020-0110-5","article-title":"Targeting cancer stem cell pathways for cancer therapy","volume":"5","author":"Yang","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbcan.2024.189104_bb0350","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.stem.2018.11.017","article-title":"Targeting cancer stemness in the clinic: from hype to hope","volume":"24","author":"Saygin","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bbcan.2024.189104_bb0355","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.4252\/wjsc.v7.i9.1185","article-title":"Therapies targeting cancer stem cells: current trends and future challenges","volume":"7","author":"Dragu","year":"2015","journal-title":"World J. Stem Cells"},{"key":"10.1016\/j.bbcan.2024.189104_bb0360","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13194814","article-title":"Cancer stem cell for tumor therapy","volume":"13","author":"Huang","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2024.189104_bb0365","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.3389\/fonc.2019.01104","article-title":"Therapeutic strategies targeting cancer stem cells and their microenvironment","volume":"9","author":"Sun","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2024.189104_bb0370","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/CMR.0b013e328348db10","article-title":"Expression of CD133 and other putative stem cell markers in uveal melanoma","volume":"21","author":"Thill","year":"2011","journal-title":"Melanoma Res."},{"key":"10.1016\/j.bbcan.2024.189104_bb0375","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1167\/iovs.18-26431","article-title":"CD166high uveal melanoma cells represent a subpopulation with enhanced migratory capacity","volume":"60","author":"Djirackor","year":"2019","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.bbcan.2024.189104_bb0380","first-page":"588","article-title":"Stem cell marker CD271 is expressed by vasculogenic mimicry-forming uveal melanoma cells in three-dimensional cultures","volume":"18","author":"Valyi-Nagy","year":"2012","journal-title":"Mol. Vis."},{"key":"10.1016\/j.bbcan.2024.189104_bb0385","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.2233","article-title":"Melanoma stem cell sphere formation assay","volume":"7","author":"Tuccitto","year":"2017","journal-title":"Bio-Protoc."},{"key":"10.1016\/j.bbcan.2024.189104_bb0390","doi-asserted-by":"crossref","first-page":"2166035","DOI":"10.1080\/14756366.2023.2166035","article-title":"ALDEFLUOR activity, ALDH isoforms, and their clinical significance in cancers","volume":"38","author":"Duan","year":"2023","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bbcan.2024.189104_bb0395","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12943-020-01173-x","article-title":"Verification of EZH2 as a druggable target in metastatic uveal melanoma","volume":"19","author":"Jin","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbcan.2024.189104_bb0400","doi-asserted-by":"crossref","first-page":"887","DOI":"10.3892\/ijo.2017.4079","article-title":"Pristimerin effectively inhibits the malignant phenotypes of uveal melanoma cells by targeting NF-\u03baB pathway","volume":"51","author":"Zhang","year":"2017","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbcan.2024.189104_bb0405","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.7150\/thno.17451","article-title":"The antihelminthic drug niclosamide effectively inhibits the malignant phenotypes of uveal melanoma","volume":"7","author":"Zhou","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.bbcan.2024.189104_bb0410","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/950658","article-title":"Salinomycin as a drug for targeting human cancer stem cells","volume":"2012","author":"Naujokat","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.bbcan.2024.189104_bb0415","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cbi.2018.09.018","article-title":"Salinomycin suppresses cancer cell stemness and attenuates TGF-\u03b2-induced epithelial-mesenchymal transition of renal cell carcinoma cells","volume":"296","author":"Liu","year":"2018","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bbcan.2024.189104_bb0420","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12943-019-1068-1","article-title":"Salinomycin effectively eliminates cancer stem-like cells and obviates hepatic metastasis in uveal melanoma","volume":"18","author":"Zhou","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbcan.2024.189104_bb0425","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12943-019-1070-7","article-title":"Transcriptional inhibition by CDK7\/9 inhibitor SNS-032 abrogates oncogene addiction and reduces liver metastasis in uveal melanoma","volume":"18","author":"Zhang","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbcan.2024.189104_bb0430","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.21873\/anticanres.12665","article-title":"The role of histone deacetylase inhibitors in uveal melanoma: current evidence","volume":"38","author":"Moschos","year":"2018","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bbcan.2024.189104_bb0435","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.canlet.2017.04.028","article-title":"In vitro and in vivo anti-uveal melanoma activity of JSL-1, a novel HDAC inhibitor","volume":"400","author":"Wang","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2024.189104_bb0440","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202317719","article-title":"LKB1-SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition","volume":"15","author":"Proteau","year":"2023","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bbcan.2024.189104_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101953","article-title":"Reactive oxygen species produced by altered tumor metabolism impacts cancer stem cell maintenance","volume":"44","author":"Tuy","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.bbcan.2024.189104_bb0450","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1158\/1078-0432.CCR-11-3237","article-title":"Molecular pathways: vasculogenic mimicry in tumor cells: diagnostic and therapeutic implications","volume":"18","author":"Kirschmann","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2024.189104_bb0455","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12040801","article-title":"Extracellular protease ADAMTS1 is required at early stages of human uveal melanoma development by inducing stemness and endothelial-like features on tumor cells","volume":"12","author":"Peris-Torres","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2024.189104_bb0460","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1152\/physrev.00005.2020","article-title":"The FGF\/FGFR system in the physiopathology of the prostate gland","volume":"101","author":"Giacomini","year":"2021","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbcan.2024.189104_bb0465","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1038\/s41388-023-02705-7","article-title":"Biological and clinical implications of FGFR aberrations in paediatric and young adult cancers","volume":"42","author":"Brown","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2024.189104_bb0470","doi-asserted-by":"crossref","first-page":"82583","DOI":"10.18632\/oncotarget.19773","article-title":"Fibroblast growth factor modulates mast cell recruitment in a murine model of prostate cancer","volume":"8","author":"Ronca","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2024.189104_bb0475","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20184599","article-title":"PTX3 modulates neovascularization and immune inflammatory infiltrate in a murine model of fibrosarcoma","volume":"20","author":"Annese","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2024.189104_bb0480","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1684\/ecn.2009.0155","article-title":"Inflammatory cells and chemokines sustain FGF2-induced angiogenesis","volume":"20","author":"Presta","year":"2009","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.bbcan.2024.189104_bb0485","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.pharmthera.2017.05.013","article-title":"Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach","volume":"179","author":"Presta","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbcan.2024.189104_bb0490","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1158\/0008-5472.CAN-19-2714","article-title":"FGF trapping inhibits multiple myeloma growth through c-Myc degradation-induced mitochondrial oxidative stress","volume":"80","author":"Ronca","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2024.189104_bb0495","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11091305","article-title":"The autocrine FGF\/FGFR system in both skin and uveal melanoma: FGF trapping as a possible therapeutic approach","volume":"11","author":"Rezzola","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2024.189104_bb0500","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ccell.2015.07.002","article-title":"Long-Pentraxin 3 derivative as a small-molecule FGF trap for cancer therapy","volume":"28","author":"Ronca","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2024.189104_bb0505","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.bbrc.2014.01.084","article-title":"The role of growth factors in maintenance of stemness in bone marrow-derived mesenchymal stem cells","volume":"445","author":"Eom","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbcan.2024.189104_bb0510","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3389\/fcell.2020.00287","article-title":"An FGFR\/AKT\/SOX2 signaling axis controls pancreatic cancer stemness","volume":"8","author":"Quan","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbcan.2024.189104_bb0515","doi-asserted-by":"crossref","first-page":"920","DOI":"10.18632\/aging.100369","article-title":"Roles of FGF signaling in stem cell self-renewal, senescence and aging","volume":"3","author":"Coutu","year":"2011","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.bbcan.2024.189104_bb0520","doi-asserted-by":"crossref","first-page":"21737","DOI":"10.1073\/pnas.1007863107","article-title":"Estrogen expands breast cancer stem-like cells through paracrine FGF\/Tbx3 signaling","volume":"107","author":"Fillmore","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbcan.2024.189104_bb0525","doi-asserted-by":"crossref","first-page":"25148","DOI":"10.18632\/oncotarget.25358","article-title":"FGFR signaling regulates resistance of head and neck cancer stem cells to cisplatin","volume":"9","author":"McDermott","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2024.189104_bb0530","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12935-023-02903-z","article-title":"FGF-trapping hampers cancer stem-like cells in uveal melanoma","volume":"23","author":"Loda","year":"2023","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bbcan.2024.189104_bb0535","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105372","article-title":"Hypoxia promotes uveal melanoma invasion through enhanced notch and MAPK activation","volume":"9","author":"Asnaghi","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2024.189104_bb0540","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s10020-021-00383-3","article-title":"Macrophages and cancer stem cells: a malevolent alliance","volume":"27","author":"Allavena","year":"2021","journal-title":"Mol. Med."},{"key":"10.1016\/j.bbcan.2024.189104_bb0545","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10555-017-9663-3","article-title":"The biology of uveal melanoma","volume":"36","author":"Amaro","year":"2017","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.bbcan.2024.189104_bb0550","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.4049\/jimmunol.0903479","article-title":"In aged mice, outgrowth of intraocular melanoma depends on proangiogenic M2-type macrophages","volume":"185","author":"Ly","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbcan.2024.189104_bb0555","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14235746","article-title":"Ten years of CRISPRing cancers in vitro","volume":"14","author":"Capoferri","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2024.189104_bb0560","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.104969","article-title":"Single-cell RNA sequencing in melanoma: what have we learned so far?","volume":"100","author":"Lim","year":"2024","journal-title":"EBioMedicine"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X24000350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X24000350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T15:13:31Z","timestamp":1778685211000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X24000350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":112,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0304419X24000350"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2024.189104","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer stem-like cells in uveal melanoma: novel insights and therapeutic implications","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2024.189104","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"189104"}}